Exiqon Announces Achievement of Primary Milestones in RNAi Project for Tacere Therapeutics
September 18, 2009
Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the successful completion of several key milestones in a custom-designed RNAi project for Tacere Therapeutics. San Jose and Copenhagen (PRWEB) -- Exiqon A/S (https://www.exiqon.com/ls) (NASDAQ OMX Copenhagen: "EXQ") today announced the successful completion of several key milestones in a custom-designed RNAi project for Tacere Therapeutics. This project [...]
Bruker Corporation Announces Proposed Secondary Offering
September 18, 2009
BILLERICA, Mass.--Bruker Corporation (NASDAQ: BRKR) today announced an underwritten public secondary offering of 12,000,000 shares of its common stock by two members of the Laukien family not involved in the Company’s business. The selling stockholders also intend to grant the underwriters a 30-day option to purchase up to an additional 1,800,000 shares of common stock [...]
Cerno Bioscience’s MassWorksTM Has Proven to be 99% Accurate Software
September 18, 2009
Cerno Bioscience’s MassWorksTM Has Proven to be 99% Accurate Software for the Identification of Unknown Compounds Cerno Bioscience has firmly established its groundbreaking leadership role in formula identification with GC/MS quadrupole instruments by its award-winning software product MassWorks. MassWorks employs Cerno’s patented calibration technology to equip unit mass resolution mass spectrometers with up to 100 [...]
AnaSpec Introduces Custom Services & Reagents for Hydrocarbon-Stapled Peptides
September 18, 2009
The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec now offers custom synthesis of hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical structure as a result of “hydrocarbon stapling.”1,2 Many biological pathways, such as signal transduction, occur because of intracellular protein-protein interactions, which [...]
September 17, 2009
New System Adds to Company’s Investigative and Analytical Research Products FARMINGDALE, N.Y.--Enzo Life Sciences, a division of Enzo Biochem, Inc. (NYSE:ENZ), has added a novel new system to its CELLestial™ line of live cell analysis products, providing expanded capability to simultaneously image both the nucleus and the nucleolus in living cells, the Company announced today. [...]
Pressure BioSciences, Inc. Announces Changes to Its Board of Directors
September 17, 2009
SOUTH EASTON, Mass. -- Pressure BioSciences, Inc. (Nasdaq:PBIO - News) ("PBI" and the "Company") today announced that Mr. P. Thomas Vogel has resigned as a member of the Company's Board of Directors, and Mr. Alan D. Rosenson has been elected to fill the newly created vacancy, each effective Tuesday, September 15, 2009. Mr. Vogel served [...]
RainDance Technologies and CLC bio Collaborate
September 17, 2009
RainDance Technologies and CLC bio Collaborate to Develop Specialized Software Solutions for Targeted Resequencing LEXINGTON, Mass. & AARHUS, Denmark--RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next generation DNA sequencing platforms. “The rapid and [...]
Meridian Bioscience Granted Special 510(k) Clearance
September 17, 2009
Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU® Test Package Insert CINCINNATI--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the company has been granted a Special 510(k) clearance to update the TRU FLU package insert to include analytical sensitivity claims with two [...]
Fluidigm’s Upcoming Stem Cell Culture Chip Status Update At World Stem Cell Summit
September 17, 2009
Fluidigm’s Upcoming Stem Cell Culture Chip to Speed Development, Reduce Complexity and Lower Costs SOUTH SAN FRANCISCO, Calif.--Fluidigm will provide the latest updates for its upcoming Stem Cell Culture Chip at the World Stem Cell Summit being held in Baltimore on September 21 – 23. This specialized integrated fluidic circuit will enable a variety of [...]
California Stem Cell and Stemina Biomarker Discovery Announce Collaboration
September 17, 2009
California Stem Cell and Stemina Biomarker Discovery Announce Collaboration to Validate Effectiveness of Human Embryonic Stem Cell-Derived Cardiomyocyte Progenitors for Use in Predictive Toxicology - CardioPlate™ 96-well assay-ready plates enable predictive toxicology and high throughput screening assays IRVINE, Calif.--Collaboration between California Stem Cell, Inc. (CSC) and Stemina Biomarker Discovery on a study using CSC’s 96-well [...]

